(Q40108361)

17 September 2017

1 reference

title

Interferons with special emphasis on the immune system (English)

1 reference

17 September 2017

Interferons with Special Emphasis on the Immune System (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

author name string

R. M. Friedman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6195895

26 August 2023

S. N. Vogel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6195895

26 August 2023

language of work or name

1 reference

1 January 1983

1 reference

17 September 2017

Advances in Immunology

1 reference

17 September 2017

34

1 reference

17 September 2017

97-140

1 reference

High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhancement of Fcγ receptor expression in interferontreated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Differential effect of human interferon on normal and neoplastic T- and B-cell lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Immune conservation: a possible consequence of the mechanism of interferon-induced antibody suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Modulating effects of interferon preparations on an antibody response in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon Preparations as Modifiers of Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibition by Interferon of Thymidine Uptake in Chemostat Cultures of L1210 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Decreased sensitivity to interferon associated within vitro transformation of X-ray-transformed C3H/10T1/2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibitory Effect of Interferon Preparations and Inducers on the Multiplication of Transplanted Allogeneic Spleen Cells and Syngeneic Bone Marrow Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Suppression of Mouse Antibody Producing Spleen Cells by Various Interferon Preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Brief communication: Cure of murine leukemia with drug and interferon treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mechanism of cellular suppression induced by oral tilorone treatment of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Host genotype influences immunomodulation by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibition by interferon of delayed-type hypersensitivity in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Delayed-Type Hypersensitivity to Sheep Red Blood Cells: Inhibition of Sensitization by Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon-induced skin reactivity in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Modulation of Lymphokine Production by Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Neutralization of the Phagocytosis-Enhancing Acitivity of Interferon Preparations by Anti-Interferon Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

A Mouse Cell Line, which Is Unprotected by Interferon against Lytic Virus Infection, Lacks Ribonuclease F Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon and cyclic-3'5'-adenosine monophosphate: potentiation of antiviral activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Expression of human immune interferon cDNA in E. coli and monkey cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Exogenous Interferon and Inducers of Interferon in the Treatment of Balb/c Mice inoculated with RC19 Tumour Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Development of newborn mice during prolonged treatment with interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Australia Antigen as a Marker of Propagation of the Serum Hepatitis Virus in Liver Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The antitumor effect of interferon in lymphocyte- and macrophage-depressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased survival in mice inoculated with tumor cells and treated with interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mechanism of the Antitumour Effect of Interferon in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Progressive glomerulonephritis in mice treated with interferon preparations at birth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Electrophoretically pure mouse interferon exerts multiple biologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Macrophage activation: increased ingestion of IgG-coated erythrocytes after administration of interferon inducers to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mononuclear phagocytes: responders to and producers of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interleukin-2 augments natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Natural killer cells: their roles in defenses against disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Macrophage Tumor Killing: Influence of the Local Environment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Immunosuppressive effects of an interferon preparation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The role of interferon in immediate hypersensitivity and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The biology of lymphocytic choriomeningitis infection: virus-induced immune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased secretion of plasminogen activator by human macrophages after exposure to leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Induction and kinetics of natural killer cells in humans following interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased binding of concanavalin A to interferon-treated murine leukemia L 1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon Induction by Lymphocytic Choriomeningitis Viruses Correlates with Maximum Virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Murine interferon system regulation: Isolation and characterization of a mutant 3T6 cell engaged in the semiconstitutive synthesis of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon inhibition of the primary in vitro antibody response to a thymus-independent antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon as a mediator of human lymphocyte suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Regulation of lymphocyte mitogenesis by (2′–5′) oligo-isoadenylate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

A cell surface alteration in mouse L cells induced by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Differential effect of interferon on ornithine decarboxylase activation in quiescent Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

1 reference

7 January 2021

Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Immunosuppressive properties of purified immune T-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Serum interferon and phagocytic activity of macrophages in recombinant inbred mice inoculated with Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mechanism of Interferon Action: Further Evidence for Transcription as the Primary Site of Action in Simian Virus 40 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mode of regulation of natural killer cell activity by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

On the heterogeneity of murine natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Modulation of target cell susceptibility to human natural killer cells by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The structure of one of the eight or more distinct chromosomal genes for human interferon-α

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Effect of Virus Infections on the Function of the Immune System

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Natural cell-mediated cytotoxicity in rats. II.In vivo augmentation of NK-cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Classification of interferons with antibody to immune interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Studies of adenovirus-SV40 hybrid viruses, VI. Differential effects of interferon on SV40 and adenovirus T antigen formation in cells infected with SV40 virus, adenoviruses, and adenovirus-SV40 hybrid viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Modulation of the human in vitro antibody response by human leukocyte interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Quantitative studies on viral interference in suspended L cells. I. Growth characteristics and interfering activities of vesicular stomatitis, Newcastle disease, and influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon effects on the growth and division of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon effects on microfilament organization cellular fibronectin distribution, and cell motility in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon inhibits the redistribution of cell surface components.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Increased spreading of macrophages from mice treated with interferon inducers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

T cell growth factor receptors. Quantitation, specificity, and biological relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Effect of priming on interferon inhibition of con A induced spleen cell blastogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Human leukocyte interferon purified to homogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Cellular interactions in the augmentation of human NK activity by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Brief Communication: Tumor Suppression by a Lymphokine Released Into the Circulation of Mice With Delayed Hypersensitivity 2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon inhibits the release of plasminogen activator from SV3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon: an inducer of macrophage activation by polyanions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Functional and morphologic characteristics of interferon-treated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Heterogeneity of poly(I) x poly(C)-induced human fibroblast interferon mRNA species

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Enhancement by interferon of natural killer cell activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

A regulatory role for interferon in immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The immunosuppressive effect of type II mouse interferon preparations on antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Time and dosoge dependence of immunoenhancement by murine type II interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Selective inhibition by interferon of serum-stimulated biochemical events in 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Double-stranded RNA synthesized in animal cells in the presence of actinomycin D.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferons: Anti-neoplastic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

The nucleotide sequence of human fibroblast interferon cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Effect of interferon on concentrations of cyclic nucleotides in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon externalization by producing cell before induction of antiviral state

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Cyclic AMP Potentiation of Interferon Antiviral Activity and Effect of Interferon on Cellular Cyclic AMP Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Inhibition of protein synthesis by 2′–5′ linked adenine oligonucleotides in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Interferon enhances 2-5A synthetase in embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Mechanism of interferon-induced inhibition of early simian virus 40 (SV40) functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

Molecular weight of human gamma interferon is similar to that of other human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960378-8

7 January 2021

9

35

282

Besancon

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

18

35

150

Buckler

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

19

35

11

Burke

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

21

35

117

Cavalieri

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

25

35

399

Chirigos

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Journal of Experimental Medicine

26 August 2023

27

426

Chun

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Experimental Cell Research

26 August 2023

29

150

73

Collyn-d'Hooghe

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

34

35

370

DeMaeyer

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Interferon preparations enhance phagocytosis in vivo

26 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

Cancer Treatment Reports

61

62

1881

Glasgow

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

80

38

4172

Grollman

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

81

35

11

Grossberg

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

82

35

1977

Guerra

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Interferon treatment of NZB mice: accelerated progression of autoimmune disease

26 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

109

35

350

Huang

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Biochimica et Biophysica Acta

26 August 2023

119

473

241

Janne

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

121

35

357

Johnson

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

Journal of Infectious Diseases

26 August 2023

126

130

52

Jordan

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

194

38

1003

Schultz

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

212

35

63

Tan

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

220

35

486

Tyrell

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

222

35

57

Vilcek

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

238

35

17

Youngner

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60378-8

26 August 2023

Identifiers

0 references

1 reference